EnWave Corporation
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Brent Charleton
- Full Time Employees
- 27
- Sector
- Producer manufacturing
- Industry
- Industrial machinery
- Address
- 1668 Derwent Way Delta BC Canada V3M 6R9
- IPO Date
- Mar 18, 1997
- Website
- enwave.net
- Similar Companies
- Business
- EnWave Corporation (TSX-V:ENW) is a Vancouver-based industrial technology company founded in 1999 that develops, licenses and sells proprietary Radiant Energy Vacuum (REV) dehydration machinery and related services for the food, pharmaceutical, cannabis and biomaterial industries worldwide. The company offers a portfolio of REV platforms including nutraREV drum-based systems and quantaREV tray-based systems in scales from 10kW batch to 120kW continuous production machines; it provides royalty-bearing intellectual property licensing for product categories such as shelf-stable dairy snacks (e.g., Cheese O’s, Moon Cheese), fruit and vegetable chips (e.g., Orto Al Sole, Dole Good Crunch), high-protein ingredients, pet treats and cannabis drying applications; additional services encompass toll processing at its REVworx facility in Delta, British Columbia, product development support via the EnWave Innovation Center, and auxiliary equipment sales. EnWave operates through over 50 royalty partners across 24 countries on five continents, targeting consumer packaged goods producers, snack brands, dairy processors and cannabis cultivators seeking superior drying efficiency, nutrient retention, microbial reduction and reduced processing times compared to freeze, air or rack drying methods. Recent developments include the closing of a fully-subscribed $3 million LIFE offering in August 2025 to fund construction of additional 60kW-120kW REV machines amid expanding order backlogs; multiple royalty-bearing license expansions and amendments in 2025 with partners such as MicroDried, Procescir S.A. de C.V., Creations Foods and Shinyway International Limited of New Zealand; sales of 120kW REV equipment to BranchOut Foods with expanded global dragon fruit rights, two 10kW machines to Dairy Concepts Irl for European dairy snacks, and additional 10kW units to U.S. and Brazilian partners; plus ongoing progress payments and commissioning for large-scale machinery with Mexican licensee Procescir. Headquarters are located in Delta, British Columbia, with global operations supported by a robust intellectual property portfolio and analyst coverage from Clarus Securities.
Company News
EnWave licenses vacuum dehydration technology to Oregon food manufacturer
EnWave licenses vacuum dehydration technology to Oregon food manufacturer
EnWave eyes $3M in royalties for fiscal 2027 - ICYMI
Canada gross domestic product rebounds in Q2 as exports, spending and investment rise
EnWave restructures manufacturing arm, eyes $1M in annual savings
Nvidia shares up 5% after-hours. Here's what the latest results print tells us about the state of AI
Prediction market traders all but rule out an Nvidia earnings miss
EnWave royalty partner launches Loovies Styx snack in Mexico
Scotiabank posts record quarter as capital markets surge lifts profit past estimates
EnWave Corporation (ENW:CA) Q3 2026 Earnings Call Transcript
EnWave posts Q3 revenue growth as royalties climb
EnWave inks R&D license agreement with University of Limerick
Goldman Sachs deepens ETF push With $2.25B Neos acquisition
BlackRock is getting ready to report, and UBS likes what it sees
Prediction markets bet on imminent GPT-5.6 launch after Commerce Department nod
Adobe reinstated at Underperform by Bank of America as AI pressures growth outlook
EnWave signs second equipment deal with Procescir, names new CFO
EnWave signs second equipment deal with Procescir, names new CFO
EnWave targets Europe's cannabis market with Swiss trial – ICYMI
EnWave targets Europe’s cannabis market with Swiss trial – ICYMI